Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
The combination of **lidocaine** and **dexamethasone** is being investigated by the **University of Jordan** for the prevention of postoperative sore throat (POST) in patients undergoing general anesthesia with endotracheal intubation. Lidocaine is a local anesthetic that is applied topically as a gel (Xylocaine) to the endotracheal tube cuff to provide local analgesia and reduce mechanical irritation of the tracheal mucosa. Dexamethasone is a potent synthetic glucocorticoid administered intravenously to provide systemic anti-inflammatory effects, thereby reducing airway edema and inflammation caused by intubation trauma. This dual approach aims to minimize the incidence and severity of POST by targeting both local physical irritation and the subsequent systemic inflammatory response.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on lidocaine + dexamethasone (University of Jordan).